<- Go Home

GlycoMimetics, Inc.

GlycoMimetics, Inc., a biotechnology company, engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States. The company was founded in 2003 and is based in Monrovia, Maryland.

Market Cap

$18.7M

Volume

6.5M

Cash and Equivalents

$10.7M

EBITDA

-$32.5M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

N/A

Profit Margin

N/A

52 Week High

$3.36

52 Week Low

$0.14

Dividend

N/A

Price / Book Value

3.52

Price / Earnings

-0.49

Price / Tangible Book Value

3.52

Enterprise Value

$8.1M

Enterprise Value / EBITDA

-0.26

Operating Income

-$32.5M

Return on Equity

173.25%

Return on Assets

-72.04

Cash and Short Term Investments

$10.7M

Debt

$66.8K

Equity

$5.3M

Revenue

N/A

Unlevered FCF

-$14.3M

Sector

Biotechnology

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches